TREM2 Regulates the Removal of Apoptotic Cells and Inflammatory Processes during the Progression of NAFLD
Open accessThe DOI matches its Crossref record; 53 of the 54 references it cites were found in a registry or an index.
Abstract
Nonalcoholic fatty liver disease (NAFLD) is the most common liver pathology worldwide. In mice and humans, NAFLD progression is characterized by the appearance of TREM2-expressing macrophages in the liver. However, their mechanistic contributions to disease progression have not been completely elucidated. Here, we show that TREM2+ macrophages prevent the generation of a pro-inflammatory response elicited by LPS-laden lipoproteins in vitro. Further, Trem2 expression regulates bone-marrow-derived macrophages (BMDMs) and Kupffer cell capacity to phagocyte apoptotic cells in vitro, which is dependent on CD14 activation. In line with this, loss of Trem2 resulted in an increased pro-inflammatory response, which ultimately aggravated liver fibrosis in murine models of NAFLD. Similarly, in a human NAFLD cohort, plasma levels of TREM2 were increased and hepatic TREM2 expression was correlated with higher levels of liver triglycerides and the acquisition of a fibrotic gene signature. Altogether, our results suggest that TREM2+ macrophages have a protective function during the progression of NAFLD, as they are involved in the processing of pro-inflammatory lipoproteins and phagocytosis of apoptotic cells and, thereby, are critical contributors for the re-establishment of liver homeostasis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Other groups have shown that deletion of triggering receptor expressed on myeloid cells 2 (TREM2) in macrophages impairs efferocytosis ex vivo and exacerbates experimental MASH (16–19)”
From Impaired TIM4-mediated efferocytosis by liver macrophages contributes to fibrosis in metabolic dysfunction–associated steatohepatitis (2025) · cites this paper as [17]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Another efferocytosis receptor, TREM2, undergoes cleavage in MASH (16), and genetic deletion of Trem2 in mice is associated with MASH progression (16–19).”
From Impaired TIM4-mediated efferocytosis by liver macrophages contributes to fibrosis in metabolic dysfunction–associated steatohepatitis (2025) · cites this paper as [17]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Younossi, Z. M., Koenig, A. B., Abdelatif, D., Fazel, Y., Henry, L., & Wymer, M. (2016) · Hepatology · doi:10.1002/hep.28431 · Cited by 10,781 · cited 1×
“NAFLD is common in obese and diabetic people and roughly 25% of the global population is affected by NAFLD [2].”
BackgroundDefective LPS Signaling in C3H/HeJ and C57BL/10ScCr Mice: Mutations in Tlr4 Gene
Poltorak, A., He, X., Smirnova, I., Liu, M.-Y., Huffel, C. V., Du, X., Birdwell, D., Alejos, E., Silva, M., Galanos, C., et al. (1998) · Science · doi:10.1126/science.282.5396.2085 · Cited by 7,631 · cited 3×
“Lipopolysaccharide (LPS), the major endotoxin, induces a pro-inflammatory response via its receptor Toll-like receptor 4 (TLR4) [21].”
BackgroundInfluentialCD14, a Receptor for Complexes of Lipopolysaccharide (LPS) and LPS Binding Protein
Wright, S. D., Ramos, R. A., Tobias, P. S., Ulevitch, R. J., & Mathison, J. C. (1990) · Science · doi:10.1126/science.1698311 · Cited by 3,987 · cited 2×
“Given the impact of Trem2 on LPSmediated response (Figure 2d) and the role of CD14, an LPS-binding protein, in regulating phagocytosis directly or in cooperation with other receptors [34,35], we tested whether synergy between TREM2 and the LPS co-receptor CD14 [36] occurs and whether it contributes to the regulation o…”
BackgroundMAFLD: a consensus-driven proposed nomenclature for metabolic associated fatty liver disease
Eslam, M., Sanyal, A. J., George, J., Sanyal, A., Neuschwander-Tetri, B., Tiribelli, C., Kleiner, D. E., Brunt, E., Bugianesi, E., Yki-Järvinen, H., et al. (2020) · Gastroenterology · doi:10.1053/j.gastro.2019.11.312 · Cited by 3,286
The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)
Buzzetti, E., Pinzani, M., & Tsochatzis, E. A. (2016) · Metabolism · doi:10.1016/j.metabol.2015.12.012 · Cited by 3,119 · cited 2×
“Adipose tissue as well as gut-derived signals are implicated in the progression of NAFLD [5].”
BackgroundOxidized LDL Regulates Macrophage Gene Expression through Ligand Activation of PPARγ
Nagy, L., Tontonoz, P., Alvarez, J. G. A., Chen, H., & Evans, R. M. (1998) · Cell · doi:10.1016/s0092-8674(00)81574-3 · Cited by 1,860 · cited 2×
“Indeed, in other tissues, the uptake of low-density lipoproteins by macrophages has been shown to modulate inflammatory responses and contribute to overall disease progression [26] and, only very recently, it has also been shown that the uptake of TRL particles by BMDMs might influence pro-inflammatory gene expression…”
BackgroundImmunosuppressive effects of apoptotic cells
Voll, R. E., Herrmann, M., Roth, E. A., Stach, C., Kalden, J. R., & Girkontaite, I. (1997) · Nature · doi:10.1038/37022 · Cited by 1,787 · cited 1×
“This clearance is associated with a reduced proinflammatory response [46] and with the induction of a tissue remodeling program essential for the re-establishment of homeostasis [47].”
BackgroundResolving the fibrotic niche of human liver cirrhosis at single-cell level
Ramachandran, P., Dobie, R., Wilson-Kanamori, J. R., Dora, E. F., Henderson, B. E. P., Luu, N. T., Portman, J. R., Matchett, K. P., Brice, M., Marwick, J. A., et al. (2019) · Nature · doi:10.1038/s41586-019-1631-3 · Cited by 1,784 · cited 3×
“While the origin and transcriptional profile of macrophage populations emerging in the liver upon NAFLD have been investigated thoroughly [7–10] and resulted in the identification of a TREM2+ subset, which is either termed LAM- [9,12] or NASH-associated macrophages (NAMs) [13] and Scar-associated macrophages (SAMs) [1…”
BackgroundCollaborative Induction of Inflammatory Responses by Dectin-1 and Toll-like Receptor 2
Gantner, B. N., Simmons, R. M., Canavera, S. J., Akira, S., & Underhill, D. M. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021787 · Cited by 1,643 · cited 1×
“The synergistic interaction of receptors involved in phagocytosis has been described as a strategy to ensure efficient and prompt clearance of pathogens and potentially harmful dying cells in various experimental settings [32,33].”
BackgroundBoursier, J., Mueller, O., Barret, M., Machado, M., Fizanne, L., Araujo‐Perez, F., Guy, C. D., Seed, P. C., Rawls, J. F., David, L. A., et al. (2016) · Hepatology · doi:10.1002/hep.28356 · Cited by 1,483 · cited 1×
“In fact, it has been shown that the severity of NAFLD is associated with alterations in the intestinal microflora and even dysbiosis [18].”
Background
Cited by
Lipid-associated macrophages between aggravation and alleviation of metabolic diseases
Xu, R., Vujić, N., Bianco, V., Reinisch, I., Kratky, D., Krstic, J., & Prokesch, A. (2024) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2024.04.009 · Cited by 95
Samy, A. M., Kandeil, M. A., Sabry, D., Abdel-Ghany, A. A., & Mahmoud, M. O. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e30387 · Cited by 60
Efferocytosis in liver disease
Shi, H., Moore, M. P., Wang, X., & Tabas, I. (2024) · JHEP Reports · doi:10.1016/j.jhepr.2023.100960 · Cited by 30
Shi, H., Wang, X., Sloas, C., Gerlach, B., Yurdagul, A., Moore, M. P., Jung, E. J., Mirshahi, F., Ronzoni, L., Sanyal, A. J., et al. (2025) · Science Translational Medicine · doi:10.1126/scitranslmed.adv2106 · Cited by 30
Nucleotide metabolic rewiring enables NLRP3 inflammasome hyperactivation in obesity
Liu, D., Zhou, C., Wang, X., Luo, Z., Xu, R., Huo, S., Guo, L., Luo, X., Yang, S., Click, A., et al. (2026) · Science · doi:10.1126/science.adq9006 · Cited by 34
sTREM2 is a plasma biomarker for human NASH and promotes hepatocyte lipid accumulation
Kothari, V. M., Savard, C. E., Tang, J., Lee, S. P., Subramanian, S., Wang, S., den Hartigh, L. J., Bornfeldt, K., & Ioannou, G. N. (2023) · Hepatology Communications · doi:10.1097/hc9.0000000000000265 · Cited by 31
“[18] Wang et al[22] and Liebold et al[23] suggested that TREM2positive macrophages, also known as NASH-associated macrophages or Scar-associated macrophages, exercise a protective function by processing and removing apoptotic hepatocytes.”
BackgroundThe double-edged role and therapeutic potential of TREM2 in atherosclerosis
Zhu, B., Liu, Y., & Peng, D. (2024) · Biomarker Research · doi:10.1186/s40364-024-00675-w · Cited by 31
“In nonalcoholic steatohepatitis (NASH), TREM2 promoted the ability of macrophages to clear apoptotic cells, limiting the deterioration of NASH [79, 80].”
BackgroundTREM2+ macrophages: a key role in disease development
Wang, X., Wang, Y., Yang, L. X., Zhang, Y., & Yang, L. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1550893 · Cited by 43
Mechanisms of TREM2 mediated immunosuppression and regulation of cancer progression
Lei, X., Gou, Y., Hao, J. Y., & Huang, X. J. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1375729 · Cited by 29
“…also linked to the development of metabolic diseases, and TREM2 de fi ciency inhibits the downstream pathway of lipid-associated macrophages (LAMs) (5), which plays an important role in the onset and progression of hypercholesterolemia, atherosclerosis, and nonalcoholic fatty liver disease (6 – 8).”
BackgroundWei, S., Guan, G., Luan, X., Yu, C., Miao, L., Yuan, X., Chen, P., & Di, G. (2025) · Science Advances · doi:10.1126/sciadv.adq5786 · Cited by 27
“…MCC950, a classical inhibitor of NLRP3, restored liver regeneration and improved liver function in mice with hepatic steatosis following PHx. Recent studies have suggested that impaired macrophage efferocytosis contributes to the progression of nonalcoholic fatty liver disease (NAFLD) ( 49 , 50 ).”
TREM2-expressing macrophages in liver diseases
Wang, X., Qiu, Z., Zhong, Z., & Liang, S. (2025) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2025.04.009 · Cited by 27
TREM2 in cardiovascular diseases: Mechanisms and therapeutic perspectives
Zhu, W., Yue, Z., Wang, Y., Guo, L., & Liu, C. (2025) · Ageing Research Reviews · doi:10.1016/j.arr.2025.102774 · Cited by 20
Wang, D., Liu, J., Zhu, Q., Wei, X., Zhang, X., Chen, Q., Zhao, Y., Tang, H., & Xu, W. (2024) · Nutrients · doi:10.3390/nu16203558 · Cited by 19
Influence of Weight Loss and Weight Regain on Adipose Tissue Inflammation
Cáceres, L., Ray, A. G., Emont, M. P., & Weinstock, A. (2025) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.125.322196 · Cited by 16
Chirivi, M., Cortés-Beltrán, D., Rendon, C. J., & Contreras, G. A. (2024) · Journal of Dairy Science · doi:10.3168/jds.2023-23998 · Cited by 17
“We observed a decrease in the frequency of TREM2 ATM during CK. TREM2 cells are specialized macrophages that contain lipids and have beneficial effects such as promoting the resolution of inflammation, lipid uptake, and removal of dying cells (Liebold et al., 2023).”
BackgroundMacrophage heterogeneity and plasticity in liver injury and repair mechanisms
Zhang, T., Horn, P., Peiseler, M., & Tacke, F. (2025) · Stem Cells · doi:10.1093/stmcls/sxaf072 · Cited by 16
Mahmoudian, R., Clavero-Mestres, H., Rusu, E. C., Arredondo-Prats, V., Aguilar, C., Chicote, J. U., Martínez, S., Riesco, D., Bartra, È., Borras, A. T., et al. (2025) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2025.07.014 · Cited by 10
The multifaceted role of macrophages in kidney physiology and diseases
Ma, Y., Yang, F., Yang, J., Wang, K., Hu, J., & Wu, Q. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1642525 · Cited by 17
Biological and clinical role of TREM2 in liver diseases
Ma, K., Guo, S., Li, J., Wei, T., & Liang, T. (2024) · Hepatology Communications · doi:10.1097/hc9.0000000000000578 · Cited by 11
Macrophages in necrotic liver lesion repair: opportunities for therapeutical applications
Wang, Y., Rodrigues, R. M., Chen, C., Feng, D., Maccioni, L., & Gao, B. (2024) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00053.2024 · Cited by 11
Unveiling the impact of TREM-2+ Macrophages in metabolic disorders
Contreras, M., Matos, A. D. O., Dantas, P. H. D. S., Neto, J. R. D. C., Silva‐Sales, M., & Sales‐Campos, H. (2024) · Cellular Immunology · doi:10.1016/j.cellimm.2024.104882 · Cited by 13
The heterogeneity of monocyte-derived macrophages in MASH pathogenesis
Zhang, M., Xia, E., Li, C., Ma, S., Yang, F., Tian, S., Zhou, X., Zheng, X., Li, B., Yang, H. J., et al. (2025) · Cell Communication and Signaling · doi:10.1186/s12964-025-02562-9 · Cited by 8
“(2) Efferocytosis: In Trem2 -deficient MASH mice, elevated expression of Caspase 3 fragments and Bax proteins suggested that LAMs helped to clear apoptotic hepatocytes, thereby reducing liver damage [36].”
Wei, Z., Pan, X., Cui, X., Zhang, J., Dai, X., Zeng, Y., & Chen, X. (2025) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2025.1537388 · Cited by 7
Zhou, X., Liu, Z., Li, S., Song, Y., Sun, M., Si, Z., & Zhu, W. (2025) · Inflammation Research · doi:10.1007/s00011-025-02155-9 · Cited by 9
“Additionally, the absence of TREM2, the proinflammatory response is exacerbated, ultimately leading to aggravated hepatic fibrosis in NAFLD mouse models [ 90].”
More Than a Cleanup Crew: The Expanding Biology of Efferocytosis
Pandit, R., Hillman, H., Williams, J. W., & Yurdagul, A. (2025) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.125.323211 · Cited by 11
The role of liver macrophages in viral liver pathogenesis
Brantly, A., Yeakle, K., Bouchard, M. J., Gaskill, P. J., & Nonnemacher, M. R. (2025) · Journal of Leukocyte Biology · doi:10.1093/jleuko/qiaf088 · Cited by 7
Tsui, J. S. M., Au, D. M., Uhm, H., Wong, W., Lo, R. M. N., Jiang, Y., Ip, F. C. F., Mok, K. Y., Wong, H. Y., Kwok, T. C. Y., et al. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70586 · Cited by 8
Ouyang, R., Li, X., Hao, J., Lin, J., Lan, H. Y., Peng, J., Li, X., Tian, Z., & Sun, Y. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1708240 · Cited by 5
Liu, W., Liu, Y., Guo, X., Cao, C., Weng, S., & Peng, D. (2026) · International Immunopharmacology · doi:10.1016/j.intimp.2026.116167 · Cited by 7
ATF3-mediated inhibition of Trem2 by Toxoplasma gondii contributes to adverse pregnancy outcomes
Geng, X., Yao, T., Wang, X., Wang, J., Zhang, T., Qian, T., Liu, C., & Chen, J. (2025) · Parasites & Vectors · doi:10.1186/s13071-025-06894-w · Cited by 5
Li, Y., Wang, Y., Li, H., Gao, R., Zhang, W., & Yang, X. (2026) · Cellular Signalling · doi:10.1016/j.cellsig.2026.112509 · Cited by 4
Revelo, X. S., Fredrickson, G., Florczak, K. L., Barrow, F., DIETSCHE, K. B., Wang, H., Parthiban, P., Almutlaq, R. N., Adeyi, O. A., Herman, A., et al. (2023) · Research Square · doi:10.21203/rs.3.rs-3446960/v1 · Cited by 5
Wu, Y., Le, W., Zhang, H., & Zhu, Y. (2025) · Life Sciences · doi:10.1016/j.lfs.2025.123879 · Cited by 4
TREM2 as a possible link between Alzheimer's disease and diabetes mellitus
Chen, W., Huang, N., Huang, W., Wang, M., Luo, Y., & Huang, J. (2026) · Experimental Neurology · doi:10.1016/j.expneurol.2026.115739 · Cited by 3
Dempsey, J. L., Savard, C. E., Kothari, V. M., Tang, J., Lee, S. P., Bornfeldt, K., Carr, R. M., & Ioannou, G. N. (2025) · Gastro Hep Advances · doi:10.1016/j.gastha.2025.100828 · Cited by 4
Wei, J., Li, Z., Du, G., Chen, T., Yang, M., Yuan, Z., Zheng, Y., & Yan, X. (2026) · Cell Proliferation · doi:10.1111/cpr.70192 · Cited by 3
Correa, N. Q., Mendivil‐Perez, M., Velez‐Pardo, C., Jiménez-Del-Río, M., & Quiroz-Correa, Q. (2025) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-025-05902-7 · Cited by 1
“…that the function of TREM2 (a cell surface receptor widely expressed on astrocytes [ 53 ]) in AD is primarily related to the clearance of soluble and insoluble amyloid beta (Aβ42) aggregates [ 54] and the recognition of apoptotic cells that release phospholipids in dying cells by apoptosis [55].”
Balzer, M. S., Zhou, J., Abedini, A., Ma, Z., Hou, Y., Yadav, T., Grundmann, M., Pavkovic, M., & Suszták, K. (2026) · Journal of the American Society of Nephrology · doi:10.1681/asn.0000000995 · Cited by 2
Ariyathanapong, N., Ploypradith, K., Yoshimura, P. K., Thedrattanawong, C., Wüestefeld, T., Leelahavanichkul, A., Jin, T., Mao, L., Fang, R. H., Lee, Y., et al. (2026) · Smart Materials in Medicine · doi:10.1016/j.smaim.2026.02.001 · Cited by 3
Macrophages in MASLD: from inflammatory and metabolic crosstalk to exercise intervention
Sun, Y. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1894884 · Cited by 1
“In mice, high-fat diet (HFD) feeding has shown to sensitize hepatocytes to cytokine-induced cell death (71).”
Fredrickson, G., Florczak, K. L., Barrow, F., DIETSCHE, K. B., Wang, H., Parthiban, P., Almutlaq, R. N., Adeyi, O. A., Herman, A., Bartolomucci, A., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.06.11.544503
The Multifaced Roles of Hepatic Macrophages in MASLD
Sui, X., Wu, M., Yang, X., & Wang, Y. (2024) · Health and Metabolism · doi:10.53941/hm.2024.100004
“Increasing evidence suggests that macrophages, as ideal sensors, detect and respond to local environmental signals such as pathogens, metabolites, and unfit cells via a range of receptors such as Vsig4 and CD36 [37,38,46].”
Zhang, L., Liu, S., Zhao, Q., Liu, X.-Y., Liu, T., Zhang, Q., Liu, M.-H., & Zhao, W. (2025) · World Journal of Hepatology · doi:10.4254/wjh.v17.i2.102328
Chang, R., Jia, H., Chen, Y., Loor, J. J., Xu, Q., Ma, L., Li, M., Shen, T., Li, X., Xu, C., et al. (2025) · Journal of Dairy Science · doi:10.3168/jds.2025-26828
Zhang, A.-Y., Xie, C.-Y., Song, X., Guo, Z.-H., Shi, Y.-R., Wang, S.-Y., Yang, G.-H., Liu, Y., & Xu, T.-C. (2026) · World Journal of Biological Chemistry · doi:10.4331/wjbc.v17.i2.118705
“…in mice for > 12 weeks; peer-reviewed studies validate CRISPR-Cas9 as a reliable tool for pancreatic gene epigenetic modification Liebold et al [44], 2023 RNA interference (LNP-siRNA - mediated) Targets pancreatic macrophages, silences TREM2 mRNA, reduces TREM2 + macrophages, and improves…”
Bile acid retention in efferocytic macrophages shapes their inflammatory status during cholangitis
Jawazneh, A. A., Liebold, I., Leyk, S., Lanzloth, C., Brackrock, V., López-López, T., Graute, S., Aranda-Pardos, I., Hamley, M., Bahn, J., et al. (2026) · The Journal of Experimental Medicine · doi:10.1084/jem.20242079
“Phagocytosis of lipid-laden aH has been described to occur via TREM2 engagement in the context of metabolic dysfunction-associated fatty liver diseases (Wang et al., 2023; Liebold et al., 2023).”
Self-citationChen, Y., Sun, Y., Chen, X., Liu, Y., & Wang, H. (2026) · Targetome · doi:10.48130/targetome-0026-0031
Li, D., Huang, Y. N., Chen, X.-Q., Lp, Z., Gong, Q., Li, Q., Li, Y., Xu, Y., & Huang, W. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1886016
Meta-inflammation through the lens of macrophage programming and nutrient-sensing ghrelin signaling
Han, H. W., Kim, D. M., Eshghjoo, S., Xu, C., Liu, Z., Patil, B. S., Guo, S., & Sun, Y. (2026) · Immunometabolism · doi:10.1097/in9.0000000000000088
Shared immune core genes in nonalcoholic steatohepatitis and primary biliary cholangitis
Zhou, M., Chen, M., Chen, X., Chen, L., Wang, G., & Jinwen, Z. (2026) · npj Systems Biology and Applications · doi:10.1038/s41540-026-00818-9
Ling, H., Qiu, P., & Hu, Y. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27177920
“…249-gene intrinsic signature, includes the canonical markers TREM2—a molecule heavily implicated in promoting the efferocytosis of lipid-loaded apoptotic hepatocytes under lipotoxic stress [25,26]—and MS4A7 , which is driven by damaged steatotic hepatocytes and promotes cellular activation [27,28].”
TREM2: A Potential Target for the Targeted Therapy of Metabolic Diseases
Li, Y., Liu, S. Q., Chu, C., & Yang, J. (2026) · Mediators of Inflammation · doi:10.1155/mi/6210178
Context-Dependent Roles of Liver Macrophages in MASH
Horn, P., & Tacke, F. (2026) · Seminars in Liver Disease · doi:10.1055/a-2954-5433
Jiang, X., Ma, J., Liu, Z., & Chen, J. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1955615
“Consistent with this protective role, TREM2 deficiency impairs apoptotic cell clearance and exacerbates hepatic inflammation and fibrosis in fatty liver disease (Liebold et al., 2023).”
Dynamic Crosstalk Between TREM2+ Macrophages and the MASLD Hepatic Microenvironment
Li, X., Yu, C., Mao, A., Peng, Y., Yiyang, H., & Zhao, Y. (2026) · Biomedicines · doi:10.3390/biomedicines14102167
“CD14 can cooperate with TREM2 during recognition and clearance of dying cells [26,77,82].”
Pascu, A., Ianole, V., & Danciu, M. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27209346
“…and phagocytosis, studied frequently in neuropathology [147], and reported to have anti-inflammatory roles in non-alcoholic liver steatosis [148], triggering receptor expressed on myeloid cells 2 (TREM2)—a type I transmembrane immunoglobulin receptor expressed by macrophages [149,150]—is…”
Chen, S., Zeng, Z., Zhang, M., & Liu, X. (2026) · Research Square · doi:10.21203/rs.3.rs-10938931/v1
Zhang, Z., Tian, M., Wang, J., Ge, W., & Chen, J. (2026) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2026.1957607
Metadata
- Authors
- Liebold, I., Meyer, S., Heine, M., Kuhl, A., Witt, J., Eissing, L., Fischer, A., Koop, A., Kluwe, J., Schulze zur Wiesch, J., Wehmeyer, M., Knippschild, U., Scheja, L., Heeren, J., Bosurgi, L., & Worthmann, A.
- Affiliations
- University Medical Center Hamburg-Eppendorf (DE)
- Harvard University (US)
- I. Department of Medicine, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany
- University Hospital Ulm (DE)
- Department of Biochemistry and Molecular Cell Biology, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany
- Corresponding author
- Bosurgi, Lidia
- Worthmann, Anna
- ORCID
- Venue
- Cells
- Publisher
- MDPI AG
- Published
- 2023-01-17
- Volume
- 12
- Issue
- 3
- Pages
- 341
- ISSN
- 2073-4409 (ISSN-L)
- PMC
- PMC9913311
- OpenAlex
- W4316673371
- Cited by
- 55
- References
- 54
- Citations by year
- 2026: 19 · 2025: 22 · 2024: 10 · 2023: 4
- FWCI
- 10.94
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Cells (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- DFG (450149205-TRR333/1, LFF-FV75)
- State of Hamburg (450149205-TRR333/1, LFF-FV75)
- Mühlbauer-fundation (450149205-TRR333/1, LFF-FV75)
- Topics
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Life Sciences › Immunology and Microbiology › Immunology › Phagocytosis and Immune Regulation
- Keywords
- TREM2, non-alcoholic fatty liver disease, TREM2+ macrophages, Kupffer cells, bone marrow-derived macrophages, phagocytosis of apoptotic cells, CD14, pro-inflammatory response, liver fibrosis, liver inflammation, hepatic triglycerides, liver homeostasis
- MeSH terms
- Animals, Humans, Liver Cirrhosis, Macrophages, Membrane Glycoproteins, Receptors, Immunologic, Apoptosis, Mice, Non-alcoholic Fatty Liver Disease
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.